跳至主要内容
临床试验/NL-OMON50037
NL-OMON50037招募中2 期

Radio guided lymph node dissection in oligo metastatic prostate cancer patients - DETECT

Radboud Universitair Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Histological proven cancer of the prostate, based on prostate biopsy-core
  • At least one 68Ga/18F-PSMA-PET/CT positive metastasis in lymph nodes, located
  • Patient is scheduled and fit for robot assisted surgery (PLND or radical
  • prostatectomy +PLND).
  • Patient is suitable for PLND (and radical prostatectomy) conform institutional
  • guidelines and is not yet treated pre-operatively. (Prior prostate cancer
  • treatment is defined as prostate and/or pelvic radiotherapy, hormonal
  • treatments such as androgen deprivation therapy, prostate brachytherapy,
  • prostate cryotherapy, high intensity focused ultrasound (HIFU) and/or prostate
  • electroporation.)
  • Age>=50 years.
  • Ability to give voluntary written informed consent to participate in this

排除标准

  • No detectable lesion on the 68Ga/18F-PSMA-PET/CT with an uptake level above
  • liver uptake level.
  • Patients who are not scheduled for PLND.
  • Prior pelvic surgery assosiated with pelvic lymphadenopathy.
  • Unequivocal evidence of metastases outside the pelvis.
  • Presence of any medical condition that in the opinion of the
  • investigator/treating physician will affect patients* clinical status by
  • participating in this trial.
  • Prior prostate cancer treatment in the form of surgery, radio-, hormonal- or
  • chemotherapy.
  • Contraindication for MRI-scanning, i.e. claustrophobia, intracranial metal
  • clips, metallic bodies in the eye, implanted electric and electronic devices
  • not eligible for MRI (pacemakers, insulin pumps, cochlear implants,
  • neurostimulators).
  • Inability to lie still for at least 60 minutes or comply with imaging.
  • Contraindication for iron infusion or hypersensitivity/allergy to the active
  • substance or any of the excipients.
  • The patient is already enrolled in one or more concurrent studies, which would
  • confound the results of this study, according to the investigators.

研究者

相似试验